Olagen®
Therapeutic Segment:
Anti-psychotic
Generic Name:
Olanzapine
Description:
Olagen® ODT Tablets U.S.P. contains olanzapine is an atypical antipsychotic that belongs to the thienobenzodiazepine class.
Indication:
Schizophrenia: Oral olanzapine is indicated for the treatment of schizophrenia. Bipolar I Disorder (Manic or Mixed Episodes): Monotherapy Oral Olanzapine is indicated for the acute treatment of manic or mixed episodes associated with bipolar I disorder and maintenance treatment of bipolar I disorder. Olanzapine and Fluoxetine in Combination: Depressive Episodes Associated with Bipolar I Disorder Oral olanzapine and fluoxetine in combination is indicated for the treatment of depressive episodes associated with bipolar I disorder, based on clinical studies. Olanzapine and Fluoxetine in Combination: Treatment Resistant Depression Oral olanzapine and fluoxetine in combination is indicated for the treatment of treatment resistant depression (major depressive disorder in patients who do not respond to 2 separate trials of different antidepressants of adequate dose and duration in the current episode), based on clinical studies in adult patients.
Formulation:
- Tablets
Strength:
- 5mg
- 10mg
Pack Size:
- 10’s